Acular LS

See also: Generic Acular, Generic Acular PF

Acular LS is a brand name of ketorolac ophthalmic, approved by the FDA in the following formulation(s):

ACULAR LS (ketorolac tromethamine - solution/drops; ophthalmic)

• 
  Manufacturer: ALLERGAN
  
  Approval date: May 30, 2003
  
  Strength(s): 0.4% ^[RLD][AT]

Has a generic version of Acular LS been approved?

A generic version of Acular LS has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Acular LS and have been approved by the FDA:

ketorolac tromethamine solution/drops; ophthalmic

• 
  Manufacturer: AKORN
  
  Approval date: November 5, 2009
  
  Strength(s): 0.4% ^[AT]


• 
  Manufacturer: ALCON PHARMS LTD
  
  Approval date: November 5, 2009
  
  Strength(s): 0.4% ^[AT]


• 
  Manufacturer: APOTEX INC
  
  Approval date: November 5, 2009
  
  Strength(s): 0.4% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Acular LS. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Ketorolac tromethamine compositions for treating or preventing ocular pain
  Patent 8,008,338
  Issued: August 30, 2011
  Inventor(s): Muller; Christopher A. & Cheetham; Janet K. & Kuan; Teresa H. & Power; David F.
  Assignee(s): Allergan, Inc.
  Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
  
  Patent expiration dates:
  
  
  • May 24, 2027
    
    ✓ 
    Patent use: A METHOD OF TREATING OR PREVENTING OCULAR PAIN IN A PATIENT
  
  

See also...

• Acular LS Drops Consumer Information (Wolters Kluwer)
• Acular LS Consumer Information (Cerner Multum)
• Acular LS Advanced Consumer Information (Micromedex)
• Ketorolac Drops Consumer Information (Wolters Kluwer)
• Ketorolac Tromethamine Drops Consumer Information (Wolters Kluwer)
• Ketorolac ophthalmic Consumer Information (Cerner Multum)
• Ketorolac Ophthalmic Advanced Consumer Information (Micromedex)
• Ketorolac Tromethamine eent AHFS DI Monographs (ASHP)